Label: ABRILADA- adalimumab-afzb injection, solution

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Export only

Drug Label Information

Updated November 9, 2022

If you are a consumer or patient please visit this version.

  • PRINCIPAL DISPLAY PANEL

    127-102-303 0.4mLCarton127-102-303 0.4mLCarton127-102-303 0.4mLCase.jpg127-102-303 0.4mLCase.jpg

  • INGREDIENTS AND APPEARANCE
    ABRILADA 
    adalimumab-afzb injection, solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:61434-053
    Route of AdministrationSUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ADALIMUMAB-AFZB (UNII: FYS6T7F842) (ADALIMUMAB - UNII:FYS6T7F842) ADALIMUMAB-AFZB20 mg  in 0.4 mL
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:61434-053-0040 in 1 CASE01/14/2021
    12 in 1 CARTON
    10.4 mL in 1 SYRINGE; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    export only01/14/2021
    Labeler - Catalent Indiana, LLC (172209277)